The Orphan Drug Report profiles pharmaceutical drugs with FDA Orphan Drug Exclusivity since 2000.
The Report includes:
- The tradename, applicant, ingredient, and Orphan exclusivity expiration dates for each Orphan Drug
- Details on each NDA and product number, including Dosage, Strength, Approval Date, Therapeutic Equivalence (TE) code, Reference Listed Drug (RLD) indicator
- All FDA-listed patents covering each Orphan Drug
- More than 400 pages
- More than 90 drugs profiled
Preview the Orphan Drug Report